
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Shock resident survival guide
Introduction
Overview
Overview
Shock is the syndrome of circulatory failure that results in inadequate cellular oxygen utilization. The diagnosis of shock is based on clinical signs (eg, altered mental status, oliguria, cold and clammy skin) and biochemical abnormalities (eg, hyperlactatemia, base deficit) indicative of tissue hypoperfusion.[1] Management of shock consists of stabilization of the hemodynamic status and correction of the underlying cause.
Causes
Causes
Life Threatening Causes
Shock is a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
Cardiogenic Shock
- Arrhythmic
- Mechanical
- Acute mitral regurgitation (papillary muscle rupture, chordae tendinae rupture)
- Free wall rupture
- Hypertrophic cardiomyopathy
- Obstruction to left ventricular filling (mitral stenosis, left atrial myxoma)
- Obstruction to left ventricular outflow tract (aortic stenosis, hypertrophic obstructive cardiomyopathy)
- Ventricular septal defect
- Myopathic
- Pharmacologic
Obstructive Shock
- Decreased cardiac compliance
- Decreased ventricular preload
- Increased ventricular afterload
Hypovolemic Shock
- Fluid depletion
- Hemorrhage
Distributive Shock
Click here for the complete list of causes.
FIRE: Focused Initial Rapid Evaluation
FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.[2]
Boxes in the salmon color signify that an urgent management is needed.
Abbreviations: CBC, complete blood count; CI, cardiac index; CK-MB, creatine kinase MB isoform; CVP, central venous pressure; DC, differential count; ICU, intensive care unit; INR, international normalized ratio; LFT, liver function test; MAP, mean arterial pressure; MVO2, mixed venous oxygen saturation; PCWP, pulmonary capillary wedge pressure; PT, prothrombin time; PTT, partial prothrombin time; SaO2, arterial oxygen saturation; SBP, systolic blood pressure; SCVO2, central venous oxygen saturation; SMA-7, sequential multiple analysis-7.
Β | Β | Β | Β | Β | Β | Β | Β | Does the patient have cardinal findings that increase the pretest probability of shock?
βΒ Β Evidence of hypoperfusion
| Β | Β | |||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||
Β | YES | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | NO | ||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | ||||||||||||||||||
Β | VentilateβInfuseβPump (VIP) βΒ Β Oxygen Β± intubation with mechanical ventilation βΒ Β Normal saline 300β500 mL over 20β30 min βΒ Β Β± Norepinephrine 0.1β2.0 ΞΌg/kg/min | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||
Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||||
Β | Workup βΒ Β ECG monitor βΒ Β Pulse oximeter βΒ Β Arterial blood gas βΒ Β Central venous catheter βΒ Β CBC/DC/SMA-7/LFT/PT/PTT/INR βΒ Β Lactate βΒ Β Chest radiograph βΒ Β Echocardiography βΒ Β Foley catheter βΒ Β ICU admission βΒ Β Β± Transfusion (Indications) βΒ Β Β± Cultures of blood, urine, etc. βΒ Β Β± Pulmonary artery catheter (Indications) | ||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||||
Β | Immediate Goals βΒ Β SaO2 >90%β92% βΒ Β CVP 8β12 mmHg βΒ Β MAP >65β70 mmHg βΒ Β PCWP 12β15 mmHg βΒ Β CI >2.1 L/min/m2 βΒ Β MVO2 >60% βΒ Β SCVO2 >70% βΒ Β Hemoglobin >7β9 g/dL βΒ Β Lactate <2.2 mM/L βΒ Β Urine output >0.5 mL/kg/h | ||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||||
Β | Identify the cause | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | History of significant bleeding or direct trauma to the thoracic cavity? | Β | Β | ||||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to the next question | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Evidence of gastrointestinal hemorrhage, vomiting, diarrhea? | Β | YES, then consider and manage as hypovolemic shock | Β | |||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to the next question | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Presence of fever or hypothermia? | Β | YES, then consider and manage as septic shock | Β | |||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to the next question | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Presence of chest pain and/or ischemic findings on ECG with coronary risk factors? | Β | YES, then consider and manage as cardiogenic shock | Β | |||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to the next question | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Presence of unexplained bradycardia? | Β | Β | ||||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to the next question | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Presence of unexplained hypoxemia? | Β | YES, then consider and manage as acute pulmonary embolism | Β | |||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to the next question | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Presence of abdominal pain or low back pain? | Β | YES, then consider intra-abdominal etiologies and surgical consultation | Β | |||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to the next question | Β | Β | ||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | Presence of wheezing with hives or skin flushing? | Β | YES, then consider and manage as anaphylactic shock | Β | |||||||||||||||||||||||||||||||
Β | |||||||||||||||||||||||||||||||||||
Β | Β | Β | Β | Β | Β | Β | |||||||||||||||||||||||||||||
Β | NO, then proceed to complete diagnostic approach below | ||||||||||||||||||||||||||||||||||
Complete Diagnostic Approach
Complete Diagnostic Approach
| History |
|
| Laboratory Findings |
|
| ECG Findings |
| Radiographic Findings |
|
| Hemodynamic Profiles and Echocardiography Findings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Treatment
Treatment
Management of shock consists of stabilization of the hemodynamic status and correction of the underlying cause once it is identified.
Do’s
Do’s
- Initial Management
- Resuscitation should be initiated while investigation is ongoing. Correct the cause of shock immediately once it is identified.
- The VIP (Ventilate-Infuse-Pump) approach is useful for ensuring an orderly sequence of therapeutic-diagnostic maneuvers.[3]
- Ventilate
- Endotracheal intubation should be performed in patients with severe dyspnea, hypoxemia, or persistent or worsening acidemia (pH <7.30).
- Infuse
- A central venous catheter should be placed for the infusion of fluids and vasoactive agents and to guide fluid therapy.
- A pulmonary artery catheter should be inserted for monitoring of blood pressure and blood sampling unless shock is rapidly reversed. (Indications)
- An infusion of 300β500 ml of crystalloid fluid is usually administered during a period of 20β30 minutes.
- End point of fluid therapy can be defined as a central venous pressure (CVP) of a few millimeters of mercury (mmHg) above the baseline to prevent fluid overload.[4]
- Pump
- Vasopressors are indicated in hypotension that is severe or refractory to fluid challenge.
- Norepinephrine (0.1β2.0 ΞΌg/kg/min IV) is the first choice of vasopressor, while epinephrine (0.1β0.5 ΞΌg/kg/min IV) is reserved for severe hypotension as the second-line agent.
- Isoproterenol (0.5β5.0 ΞΌg/min IV) should be limited to the treatment of hypotensive patients with severe bradycardia.
- Adjunctive vasopressin (0.01β0.04 U/min IV) to norepinephrine should be considered only in hyperdynamic phase of distributive shock.
Don’ts
Don’ts
- Do not test orthostatic hypotension in hypotensive patients.
- Do not rely solely on SpO2 readings from pulse oximeter. SaO2 from blood gas analysis provides more precise status of oxygenation.
- Do not administer low-dose dopamine (<5 ΞΌg/kg/min) to preserve renal function in patients with shock.
References
References
- β 1.0 1.1 Vincent, JL.; De Backer, D. (2013). “Circulatory shock”. N Engl J Med. 369 (18): 1726β34. doi:10.1056/NEJMra1208943. PMIDΒ 24171518. Unknown parameter
|month=ignored (help) - β Rosen, Peter; Marx, John A. (2013). Rosen’s emergency medicineΒ : concepts and clinical practic. Philadelphia, PA: Elsevier/Saunders. ISBNΒ 978-1-4557-0605-1.
- β Weil, MH.; Shubin, H. (1969). “The VIP approach to the bedside management of shock”. JAMA. 207 (2): 337β40. PMIDΒ 5818156. Unknown parameter
|month=ignored (help) - β Dellinger, RP.; Levy, MM.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, SM.; Sevransky, JE.; Sprung, CL.; Douglas, IS. (2013). “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012”. Crit Care Med. 41 (2): 580β637. doi:10.1097/CCM.0b013e31827e83af. PMIDΒ 23353941. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, MBChB. [2]
